English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/169352
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Novel clinical and molecular findings in Spanish patients with naevoid basal cell carcinoma syndrome

AuthorsAlonso, N.; Cañueto, Javier; Ciria, S.; Bueno, Elena; Palacios-Alvarez, I.; Alegre, M.; Badenas, C.; Barreiro, A.; Pena, Laura; Maldonado, C.; Nespeira-Jato, M. V.; Peña-Penabad, C.; Azon, A.; Gavrilova, M.; Ferrer, I.; Sanmartin, O.; Robles, L.; Hernández-Martín, Angela; Urioste, Miguel; Puig, S.; Puig, L.; González-Sarmiento, Rogelio
Issue Date2018
PublisherJohn Wiley & Sons
British Association of Dermatologists
CitationBritish Journal of Dermatology 178(1): 198-206 (2018)
Abstract[Background]: Naevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant disorder characterized by developmental alterations and multiple basal cell carcinomas. Mutations in PTCH1, which encodes a membrane receptor for Sonic Hedgehog, are associated with the development of the disease. Most of them produce a truncated protein, which is unable to suppress Smoothened protein and continuously activates the downstream pathway. [Objectives]: We aimed to characterize 22 unrelated Spanish patients with NBCCS, the largest cohort with Gorlin syndrome reported to date in Spain. [Methods]: Genomic analysis of PTCH1 was performed in patients with NBCCS and controls, and mutations were analysed using bioinformatics tools. [Results]: We report for the first time two young patients, one each with uterus didelphys and ganglioneuroma, within the context of NBCCS. One patient showing a severe phenotype of the disease had developed basal cell carcinomas since childhood. Sanger sequencing of PTCH1 in this cohort identified 17 novel truncating mutations (11 frameshift, five nonsense and one mutation affecting an exon–intron splice site) and two novel missense mutations that were predicted to be pathogenic. The patients showed great clinical variability and inconsistent genotype–phenotype correlation, as seen in relatives carrying similar mutations. [Conclusions]: This study contributes to increase the pool of clinical manifestations of NBCCS, as well as increasing the number of pathogenic mutations identified in PTCH1 predisposing to the condition. The inconsistencies found between phenotype and genotype suggest the involvement of other modifying factors, genetic, epigenetic or environmental.
URIhttp://hdl.handle.net/10261/169352
Identifiersdoi: 10.1111/bjd.15835
e-issn: 1365-2133
issn: 0007-0963
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.